To study the mechanisms that activate expression of the atrial natriuretic factor (ANF) gene during pressure-induced hypertrophy, we have developed and characterized an in vivo murine model of myocardial cell hypertrophy. We employed microsurgical techniques to produce a stable 35-to 45-mmHg pressure gradient across the thoracic aorta of the mouse that is associated with rapid and transient expression of an immediate-early gene program (c-fos/cjun/junB/Egr-1/nur-77), an increase in heart weight/body weight ratio, and up-regulation of the endogenous ANF gene. These responses that are identical to those in cultured cell and other in vivo models of hypertrophy. To determine whether tissue-specific and inducible expression of the ANF gene can be segregated, we used a transgenic mouse line in which 500 base pairs of the human ANF promoter region directs atrial-specific expression of the simian virus 40 large tumor antigen (T antigen), with no detectable expression in the ventricles. Thoracic aortic banding of these mice led to a 20-fold increase in the endogenous ANF mRNA in the ventricle but no detectable expression of the T-antigen marker gene. This result provides evidence that atrial-specific and inducible expression of the ANF gene can be segregated, suggesting that a distinct set of regulatory cis sequences may mediate the up-regulation of the ANF gene during in vivo pressure overload hypertrophy. This murine model demonstrates the utility of microsurgical techniques to study in vivo cardiac physiology in transgenic mice and should allow the application of genetic approaches to identify the mechanisms that activate ventricular expression of the ANF gene during in vivo hypertrophy.
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In response to diverse stimuli, such as hypertension, valvular heart disease, and endocrine disorders, the myocardium adapts to increased workloads through the hypertrophy of individual muscle cells (for a review, see refs. 1 and 2). Although the signaling mechanisms that mediate the hypertrophic response of cardiac muscle cells remain unclear, transcriptional activation of cardiac target genes, including contractile proteins and embryonic markers, appears to play a pivotal role in this adaptive response (3, 4) . In this regard, the reactivation of atrial natriuretic factor (ANF) gene expression in ventricular cells occurs in response to diverse hypertrophic stimuli (genetic, hormonal, volume overload, pressure overload, hypertension, etc.) in multiple species (5-11), including humans, and could be considered one of the conserved features of ventricular cell hypertrophy.
To study the transcriptional regulation of cardiac genes, workers in our laboratory (3, 12, 13) and others (14) (15) (16) have extensively characterized cultured myocardial cell models in which several features of hypertrophy can be induced after stimulation with defined agents, such as a-adrenergic agonists (3, 12, (14) (15) (16) (17) or endothelin 1 (13) . In this model, the inducibility of a constitutively expressed contractile protein gene, myosin light chain 2 (MLC-2), is mediated by conserved cis regulatory elements (HF-1 and HF-2), which also are involved in cardiac-specific expression (17) . Extensive mutagenesis studies have been unable to segregate cardiacspecific and inducible expression within a 250-base-pair (bp) fragment of the MLC-2 promoter, which confers both responses (17, 18 (3, 4, (12) (13) (14) (15) (16) (17) , it would also be of particular value to critically examine the relevance of studies in in vitro models to pressure overload hypertrophy in the in vivo setting. The current study describes the development of an in vivo murine model of pressure overload hypertrophy to directly address this question in normal and transgenic mice. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. a narrowing 0.4 mm in diameter when the needle was removed and a reproducible transverse aortic constriction (TAC) of 65-70%. For chronic studies, neither carotid artery was cannulated, the pneumothorax was evacuated, and the animals were extubated and allowed to recover. The overall mortality rate for animals that recovered from anesthesia in this chronic thoracic model was 10%, while the operative mortality for both the acute and chronic studies was 4%.
METHODS
Northern and Immunoblotting Analyses. Immunoblotting, immunofluorescence, and Northern blotting analyses were performed by modifications of described methods (3, 12, 13) .
RESULTS AND DISCUSSION
The present study reports the development ofa microsurgical technique for the reproducible induction ofpressure overload Proc. Natl. Acad. Sci. USA 88 (1991) hypertrophy with an acceptable mortality (10%1), and a success rate (>70%) that compares favorably with larger animal models (19, 20) . In the course of operating on >300 mice, a number of critical experimental variables were optimized (intubation and respiratory control, the duration and extent of anesthesia, intraoperative technique, and catheter design/ placement). A schematic of the surgical preparation is displayed in Fig. 1 (Upper Left). To determine the diameter of the major vessels, a silastic elastomer was infused under pressure (100 mmHg; 1 mmHg = 133 Pa) to form a cast of the arterial tree in one adult mouse of the same approximate weight as in these studies (Inset) . The diameters of the right and left carotid arteries at the site of cannulation were 0.56 and 0.48 mm, respectively, while the diameter of the transverse aorta at the site of where constrictions were performed was 1.2 mm. . Physiologic and Morphologic Assessment of Hypertrophy After Chronic Aortic Constriction. After 7 days of chronic pressure overload, a 41% -increase in heart wet weight (n = 18, TAC; n = 10, sham) and a 30%o increase in heart dry weight (n = 11, TAC; n = 6, sham) occurred in the hypertrophied hearts compared to sham-operated hearts (P < 0.001 and P < 0.05, respectively). A 33% increase in wet and a 24% increase in dry heart weight/body weight ratio resulted from chronic constriction of the thoracic aorta ( Fig. 1 Upper Right). The cross-sectional area of myocytes (mean cell area at the nucleus) increased from 121.9 ± 43.1 to 163.7 ± 56.9 (P < 0.001) ,um2 in the hypertrophied ventricles (n = 4 or 5).
No evidence for ischemic necrosis or fibrous scar formation was observed in any region (inner, mid, outer wall) of the left ventricle or papillary muscles.
Induction of Immediate-Early Gene Program. In vivo pressure overload rapidly activated a program ofimmediate-early gene expression (Fig. 2) , including c-fos/c-jun/jun-B (21)/ Egr-1 (12)/nur77 (22) , which is an essential feature of both in vivo and in vitro models of hypertrophy (12, (23) (24) (25) (26) . A fos-related antigen, fra-1, which is inducible during serum stimulation of several cell types and is usually coregulated with the other immediate-early genes (27) , was not expressed after the induction of pressure overload. Thus, a distinct subset of immediate-early genes was rapidly induced after in vivo pressure overload in murine myocardium. This pattern appeared to be identical to that observed during a-adrenergicmediated hypertrophy of neonatal rat myocardial cells, and distinct for cardiac cells, as serum stimulation of fibroblasts induces a different pattern of immediate-early gene expression, which includes the activation offra-) (27) .
The identification of similar patterns of immediate-early gene expression during in vivo pressure overload hypertrophy of adult myocardium and agonist-mediated hypertrophy of neonatal rat myocardial cells suggests the possibility that conserved mechanisms might orchestrate cardiac gene expression, independent of the hypertrophic stimulus. Since the induction of constitutively expressed contractile protein genes (e.g., the MLC-2 gene) and the activation of a program of embryonic gene expression (e.g., the ANF gene) occur during many forms of in vitro and in vivo hypertrophy, the possibility exists that conserved mechanisms might mediate the inducibility ofthese central genetic features ofmyocardial cell hypertrophy. However, it should be emphasized that the precise role of a-adrenergic stimulation and immediate-early genes in the activation of the in vivo hypertrophic response is currently unknown.
Induction of the Endogenous ANF Gene. Thoracic aortic banding of the mouse aorta leads to a marked increase in the expression of the ANF gene in the hypertrophied ventricle, consistent with the activation of an embryonic program of gene expression (Fig. 3) . After 1 week of thoracic banding, ANF mRNA levels are significantly increased to >20-fold of the control level, similar to results obtained in other in vivo and in vitro models of myocardial cell hypertrophy (5) (6) (7) (8) (9) (10) (11) . This result provided further evidence for the activation of the hypertrophic response in the mouse model and suggested its utility in the study of mechanisms that mediate transcriptional activation of the ANF gene during chronic pressure overload. Studies in ANF-Large Tumor Antigen (T antigen) Transgenic Mice. For these studies, we used a well characterized line of transgenic mice that harbor an ANF-T-antigen fusion gene (28, 29) . The transgene consists of a 500-bp fragment of the human ANF 5' flanking region fused to coding sequences for the simian virus 40 (SV40) T antigen. The 500-bp ANF promoter fragment directs atrial-specific expression of T antigen, with no detectable expression in the ventricle, similar to the tissue-restricted expression of the endogenous ANF gene (30) . To determine whether these sequences, which confer atrial-specific expression of the ANF gene, would also be sufficient to confer inducible expression during ventricular cell hypertrophy, thoracic banding (7 days) was induced in a series of mice derived from this ANF-T-antigen transgenic line (ANF-TAG 52). As assessed by Northern blotting, thoracic banding of these transgenic mice led to a marked induction of the endogenous ANF gene (Fig. 4A) . However, as assessed by either Northern blotting (Fig. 4B) or immunoblotting with T-antigen antiserum (Fig. 4C) , transgene expression was not significantly induced in the ventricle. Similarly, immunofluorescence with antibodies suitable for the single cell detection of T-antigen expression (33) resulted in no evidence of positive staining in the ventricles, while the atria showed markedly positive staining for T antigen (data not shown). Taken together, these results suggest that two important functions of the ANF promoter region-i.e., the maintenance of atrial-restricted expression and the up-regulation of ANF gene expression during ventricular hypertrophy-can be segregated during mechanical overload in this transgenic mouse line. Since previous studies of the rat cardiac MLC-2 gene have suggested that a similar set of conserved cis regulatory elements can confer both cardiac-specific and inducible expression during myocardial cell hypertrophy (17) , the results of the present study suggest It remains to be determined whether a similar set of cis regulatory sequences will mediate the activation ofANF gene expression in the embryonic ventricle and the induction of the ANF gene in the hypertrophied adult ventricular cell in vivo. Previous studies from our laboratory have documented that T antigen can be expressed to relatively high levels in neonatal rat ventricular cells without the loss of cell viability (33) . Thus, it would appear that the T-antigen mRNA is not unstable in the ventricular cells and that this does not represent a significant limitation to the current studies. In addition, mice harboring a myosin heavy chain promoter-Tantigen construct have been demonstrated to express T antigen in the ventricle in a tissue-specific fashion (L.F., unpublished observations). This also would argue that the expression of the T antigen in the transgenic mice is not lethal and/or toxic. Finally, it is possible, although unlikely, that the observed effects are simply due to the site of integration. The frequency of ANF-T-antigen founders in the initial generation of the mice was not consistent with atrial expression of the T antigen being a rare, selected event. In addition, the position-dependent effect would have to selectively affect expression in the atrium versus the ventricle, since there is a high level of expression of T antigen in the atrium, as noted in our Northern blotting studies with total RNA. (31) . Immunoblotting of T antigen was visualized with a horseradish peroxidase-diaminobenzidine coupled reaction, as described (32 (29) .
Previous studies in cultured myocardial cells have documented that a 638-bp fragment of the rat ANF promoter is sufficient to confer inducible expression to a luciferase reporter gene (31) . Since 
